Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - CHEMBIO DIAGNOSTICS, INC. | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - CHEMBIO DIAGNOSTICS, INC. | ex31_1.htm |
| EX-23.1 - EXHIBIT 23.1 - CHEMBIO DIAGNOSTICS, INC. | ex23_1.htm |
| EX-21.1 - EXHIBIT 21.1 - CHEMBIO DIAGNOSTICS, INC. | ex21_1.htm |
| EX-10.3 - EXHIBIT 10.3 - CHEMBIO DIAGNOSTICS, INC. | ex10_3.htm |
| 10-K - 10-K - CHEMBIO DIAGNOSTICS, INC. | form10k.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K (the “Report”) of Chembio Diagnostics, Inc. (the “Company”) for the year ended December 31, 2019, each of the undersigned Gail S. Page, the President & Interim
Chief Executive Officer of the Company, and Neil A. Goldman, the Executive Vice President & Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of the undersigneds’ knowledge and belief:
| (1) |
This Form 10-K for the year ended December 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
| (2) |
The information contained in this Form 10-K for the year ended December 31, 2019 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented
therein.
|
|
Dated: March 13, 2020
|
/s/ Gail S. Page
|
|
|
Gail S. Page
|
||
|
President & Interim Chief Executive Officer
|
|
Dated: March 13, 2020
|
/s/ Neil A. Goldman
|
|
|
Neil A. Goldman
|
||
|
Executive Vice President & Chief Financial Officer
|